Shilpa Medicare’s active pharmaceutical ingredient (API), octreotide, is used in the treatment of conditions such as acromegaly and severe diarrhoea, among others. Shares of Shilpa Medicare Ltd ended at ₹861, down by ₹11.90, or 1.36%, on the BSE.
Shilpa Medicare’s active pharmaceutical ingredient (API), octreotide, is used in the treatment of conditions such as acromegaly and severe diarrhoea, among others. Shares of Shilpa Medicare Ltd ended at ₹861, down by ₹11.90, or 1.36%, on the BSE.